An optical molecular imaging system was used to evaluate the tissue distribution and tumor targeting capability of DF-HSA in pancreatic carcinoma MIA PaCa-2 xenograft-bearing mice. This evidence concerns the gene ALB and exocrine pancreatic carcinoma.